Portal de investigación
Retirada del Tratamiento Betabloqueante en Pacientes con Insuficiencia Cardíaca con Función Sistólica Preservada e Incompetencia Cronotrópica. Efecto sobre la Capacidad Funcional.
Datos básicos
- Protocolo:
- PI17/01426
- EUDRACT:
- NCT:
- Centro:
- HOSPITAL CLINICO UNIVERSITARIO DE VALENCIA
- Año de incio:
- 2018
- Año de finalización:
- 2021
Documentos
- No hay documentos
Participantes
Grupos y Plataformas de I+D+i
Financiadores - Promotores
INSTITUTO SALUD CARLOS III
Resultados del Ensayo Clínico
Association between N-terminal pro-brain natriuretic peptide and maximal functional capacity in heart failure with preserved ejection fraction: The modifying role of obesity.
Article. 10.1016/j.orcp.2024.05.005. 2024
Beta-blockers withdrawal in patients with heart failure with preserved ejection fraction and chronotropic incompetence: Effect on functional capacity rationale and study design of a prospective, randomized, controlled trial (The Preserve-HR trial)
Palau, P; (...); Nunez, J
Article. 10.1002/clc.23345. 2020
Chronotropic index and long-term outcomes in heart failure with preserved ejection fraction
Palau, Patricia; (...); Nunez, Julio
Article. 10.1016/j.rec.2022.08.003. 2023
Effect of ß-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
Article. 10.1016/j.jacc.2021.08.073. 2021
Reply: Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
Letter. 10.1016/j.jacc.2022.01.002. 2022
Right Ventricular Dysfunction Staging System for Mortality Risk Stratification in Heart Failure with Preserved Ejection Fraction
Article. 10.3390/jcm9030831. 2020
